The presence of a serious adverse event that represents any hazard for the patient and/or requires immediate medical or surgical intervention will force the discontinuation of the treatment and initiation of pertinent medical management. The research staff will notify the Adverse Event Committee (AEC) of the FCV of any serious adverse event within 24 hours of its documentation.